McDonald's plans to expand protein-forward menu options for households using GLP-1 drugs, medications associated with weight loss and diabetes treatment. McDonald's USA president Skye Anderson said 84% of households with GLP-1 users visit the chain, presenting an opportunity as eating habits change. Customers taking the medications tend to order Chicken McNuggets, Filet-O-Fish and Happy Meals, while seeking food that feels satisfying without being excessive. The company is considering salads topped with McCrispy strips, grilled chicken and egg bites, alongside other protein-focused offerings across breakfast, lunch and dinner. CEO Chris Kempczinski said the changes represent a long-term strategy rather than an immediate, systemwide launch, with local franchisees and market-level GLP-1 adoption influencing availability. PwC data indicates that GLP-1 household spending at quick-service restaurants fell nearly 9% after six to eight months of medication use, while many users want smaller portions and pricing changes.